BULLETIN
CSQ-Bulletin92
CSQ-Bulletin92
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Page 18 | Bulletin 92 | July 2015<br />
niaa@rcoa.ac.uk www.niaa.org.uk<br />
roles for all members of the group. This<br />
will help to ensure that we recognise<br />
the role of individual CTG members,<br />
even though CTG projects will be large<br />
collaborations. The CTG will also build<br />
relationships with clinical trials units<br />
that have expertise in trial design<br />
and management, with major public<br />
research funders and with other trials<br />
groups in related specialties in the UK<br />
and internationally.<br />
What type of research question<br />
will the CTG focus on?<br />
The scope of the CTG will primarily<br />
be to support projects involving the<br />
recruitment of patients where the aim<br />
is to improve outcomes for patients<br />
undergoing surgical treatment. In<br />
general, this will not include research<br />
into surgical techniques except<br />
where there is a clear overlap with<br />
perioperative medicine. Similarly,<br />
clinical trials that fall clearly under the<br />
remit of intensive care medicine are<br />
already well served by the Intensive<br />
Care Foundation (ICF). 3 It is likely<br />
that for such topics, the CTG will<br />
only engage when there is a clear<br />
perioperative medicine question to<br />
answer and, this will probably be<br />
undertaken collaboratively with the<br />
ICF and other relevant players. It is<br />
anticipated that the primary focus will<br />
be on large clinical trials enrolling<br />
500+ patients but there will also be<br />
opportunities for some smaller studies<br />
to gain CTG support, especially if they<br />
are likely to translate into subsequent<br />
larger Phase II/III trials.<br />
How can I take part?<br />
The process of establishing the CTG<br />
is under way, and the first major<br />
task will be to appoint a Director and<br />
Executive Board that will then develop<br />
the framework by which the group will<br />
operate. Once this is in place, the CTG<br />
will begin the process of recruiting<br />
individual investigators. Key initiatives<br />
are likely to include an accredited local<br />
investigators scheme and an accredited<br />
principal investigators scheme. These<br />
schemes will provide training days and<br />
other resources to support and develop<br />
investigators in individual hospitals or<br />
training schemes. When established,<br />
investigators will be able to update<br />
their training once every two years in<br />
line with Good Clinical Practice for<br />
research guidance. 4 We aim to recruit<br />
at least one hundred members to each<br />
scheme within two years of the CTG<br />
launch. In addition, the CTG will run<br />
a more intensive chief investigator<br />
training and mentorship programme<br />
for a small number of talented<br />
individuals who wish to lead their own<br />
clinical trials.<br />
When will this happen?<br />
The role of CTG Director was advertised<br />
in February, and will be interviewed<br />
for and appointed to in June 2015.<br />
This appointment will be followed by<br />
recruitment of the CTG Executive Board<br />
members. Following this, we will actively<br />
seek applications for CTG membership<br />
in the various categories, leading up<br />
to a formal launch in spring 2016. The<br />
selection of the first ‘pathfinder’ studies<br />
will begin by the end of 2015. The first<br />
job of the Director and Board will be<br />
to establish the transparent and open<br />
processes and governance that will<br />
underpin the identification, selection<br />
and development of high quality<br />
candidate studies.<br />
Watch this space<br />
Regular updates on progress with<br />
the CTG will be posted on the NIAA<br />
website at: http://bit.ly/1HKuWKJ.<br />
Please share your contact details with<br />
us if you wish to express interest in<br />
joining the CTG. The CTG offers a<br />
massive opportunity to transform the<br />
clinical trial research landscape within<br />
our specialty. Most importantly,<br />
it brings the promise of practice<br />
changing perioperative research for<br />
patient benefit.<br />
References<br />
1 The Rosetrees Trust<br />
(www.rosetreestrust.co.uk) (accessed 27<br />
April 2015).<br />
2 Perioperative Medicine: The<br />
Pathway to Better Surgical Care<br />
(www.rcoa.ac.uk/perioperativemedicine)<br />
(accessed 27 April 2015).<br />
3 The Intensive Care Foundation<br />
(www.ics.ac.uk/icf) (accessed 27 April<br />
2015).<br />
4 Guidelines for good clinical practice<br />
in clinical trials. MRC, 1998<br />
(http://bit.ly/1EdVYYv) (accessed<br />
27 April 2015).<br />
NIAA<br />
National Institute of Academic<br />
Anaesthesia<br />
BJA/NIAA RESEARCH<br />
METHODOLOGY<br />
WORKSHOP<br />
Monday, 5 October 2015<br />
Monday, 21 March 2016<br />
Tuesday, 7 June 2016<br />
RCoA, London<br />
£150<br />
CPD Matrix code covered: 3J03<br />
Event organiser:<br />
Professor P Hopkins<br />
9.00 am<br />
Registration<br />
A joint workshop with the British<br />
Journal of Anaesthesia and the<br />
National Institute of Academic<br />
Anaesthesia to introduce<br />
participants to the way in<br />
which good research should be<br />
conducted and presented.<br />
The workshop will be useful for<br />
anaesthetists of any grade who<br />
are already involved in research or<br />
those who are about to embark on<br />
a research project.<br />
4.30 pm<br />
Close<br />
5<br />
CPD<br />
CREDITS